To move forward with the most potent DARPins, the second-series DARPins 55.2 and 57.2, which show strong binding to human CD4 and inhibition of HIV infection in vitro[8], were examined for macaque reactivity. The gene discussed is CD4; the disease is HIV infectious disease.